WHO backs Regeneron COVID-19 drug cocktail - with equal access and price cut

The Regeneron antibody drug cocktail – casirivimab and imdevimab – has been added to the World Health Organization’s (WHO) list of treatments for COVID-19 patients, the UN agency said on Friday, before underscoring the need for lower prices and equitable distribution. 

Read the full story, “WHO backs Regeneron COVID-19 drug cocktail - with equal access and price cut”, on globalissues.org →

from Global Issues News Headlines https://ift.tt/3zKGyMM
via IFTTT